PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.

• M. Eleonora,
• M. Larisa,
• S. Vadim,
• S. Maxim,
• F. Maia,
• G. Irina,
• K. Sergey,
• S. Anton,
• M. Elisabeth,
• A. Alexandra

Affiliations

M. Eleonora

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia

M. Larisa

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia

S. Vadim

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia

S. Maxim

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia

F. Maia

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia

G. Irina

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia

K. Sergey

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia

S. Anton

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia

M. Elisabeth

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia

A. Alexandra

1 Federal State-Funded Institution «National Research Center for Hematology» of the Ministry of Healthcare of Russia, Moscow, Russia